CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,581 | -39.8% | 230,000 | 0.0% | 0.00% | – |
| Q2 2023 | $135,493 | +3.3% | 230,000 | 0.0% | 0.00% | – |
| Q1 2023 | $131,215 | -14.5% | 230,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $153,410 | -54.3% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $336,000 | +35.5% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $248,000 | -64.7% | 230,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $702,000 | -21.6% | 230,000 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $895,000 | -26.2% | 230,000 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $1,212,000 | -11.0% | 230,000 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,362,000 | -16.7% | 230,000 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $1,635,000 | – | 230,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 458,466 | $1,783,000 | 0.72% |
| Affinity Asset Advisors, LLC | 400,000 | $1,548,000 | 0.56% |
| Sio Capital Management, LLC | 422,598 | $1,644,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,977,000 | 0.22% |
| Ikarian Capital, LLC | 99,422 | $385,000 | 0.06% |
| PURA VIDA INVESTMENTS, LLC | 102,324 | $398,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 322,373 | $1,254,000 | 0.01% |
| NEXT Financial Group, Inc | 23,852 | $93,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $895,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 67,600 | $263,000 | 0.00% |